Mylan, a champion for Women's Health
Most Indian women experience health challenges throughout their lifetime, from adolescence to post-menopausal age. Mylan is committed to address the major health concerns among women in India, and aims to tackle these health issues in coordination with the Indian medical community, thereby ensuring timely access to affordable treatment and improving the quality of life for Indian women.
Health is an important factor that contributes to human well being and economic growth.
As in several countries, in India too, women do not have easy access to healthcare, which greatly compromises their social and economic status. From risks of miscarriages, infertility and other post-menopause related complications, women in India face numerous health issues, which ultimately affects the aggregate economy’s output.
Approximately one in five pregnancies in Indian women end in miscarriage. In addition, women who are in post-menopause may experience various short, medium and long-term complications, such as urogenital atrophy or osteoporosis.
Mylan aims to tackle these health issues through its women’s care segment, which focuses on treatments such as hormone replacement therapy, pre and post natal supplementation, post-menopause care and in-vitro fertilization treatments, such as follicle stimulating hormones, human menopausal gonadotropins and human chorionic gonadotropins.
Women in India face a number of health challenges, In addition, women who are in post-menopause may experience various short, medium and long term complications, such as urogenital atrophy or osteoporosis.
In addition to launching our innovative, high quality product portfolio, Mylan helps strengthen the capabilities of healthcare providers in this area through training programs and workshops, working together with the medical community, government and non-government organizations to address areas of concern in women's health and improve timely access to appropriate high quality treatment.
Mylan’s women’s health business spans more than 60 emerging-market countries, touching the lives of approximately 15 million women.